Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06122090 · ClinicalTrials.gov registry record · Phase 2
Treatment of Hypopigmented Scars With Bimatoprost
A Phase 2 study of Scarring and Scars, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06122090: Recruiting Phase 2 study of Scarring and Scars, sponsored by Medstar Health Research Institute.
NCT06122090 is a Phase 2 study of Scarring and Scars that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 25 participants, below the 80-participant average among 8 other Scarring trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06122090, a Phase 2 study of Scarring and Scars, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients who have hypo-pigmented burn scar will have two scars chosen and randomized to treated scar and control scar. The subject will then have both scars treated with fractional ablative CO2 laser (FLSR). The treated scar will have bimatoprost delivered through the laser channels, while the control will have the vehicle (normal saline) only delivered. The treatment will continue for 14 days with twice daily application. The scars will then be monitored at a 2-week follow-up visit where levels of melanin will be evaluated. Tissue punch biopsies will also be used to evaluate the mechanism of action of bimatoprost. Treatment will occur for 6 sessions at 4-6 week intervals including follow- up visits and evaluations.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Bimatoprost
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-18 |
| Est. Completion | 2025-07-31 |
| Phase | Phase 2 |
What NCT06122090 shows while recruiting
NCT06122090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 80-participant average among 8 other Scarring trials with a reported enrollment target (69% lower).
The record links to 9 conditions, with Scarring appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06122090 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06122090 about?
NCT06122090 is a clinical study titled "Treatment of Hypopigmented Scars With Bimatoprost". Patients who have hypo-pigmented burn scar will have two scars chosen and randomized to treated scar and control scar. The subject will then have both scars treated with fractional ablative CO2 laser (FLSR). The treated scar will have bimatoprost delivered through the laser channels, while the contr...
What is the current status of trial NCT06122090?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2023-07-18. Estimated completion is 2025-07-31.
What conditions does trial NCT06122090 study?
This clinical trial studies the following conditions: Scarring, Scars, Burn Scar, Cicatrix, Hypopigmented Scar.
What interventions are being tested in trial NCT06122090?
The interventions under investigation include: Saline (DRUG), Bimatoprost (DRUG).
Who is sponsoring clinical trial NCT06122090?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06122090 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scarring
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06122090's enrollment target sits among peer trials
25 9th of 8 the lowest of 8 other Scarring trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scarring trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery
COMPLETED · Phase 2
-
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
RECRUITING · NA
-
Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
RECRUITING · NA
-
Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure
RECRUITING · NA
-
Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds
RECRUITING · NA
-
Amniotic Membrane in Total Knee Replacements to Reduce Scarring
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI